Blog
MD Anderson Scientist Awarded Research Grant
Can an epigenetic enzyme under the right conditions contribute to the growth of cancer cells? If so, what happens if the enzyme is removed? Can
May 23, 2018
No Comments
Category: For Researchers
About NETRF
The Neuroendocrine Tumor Research Foundation (NETRF) is the leading private funder of research into causes and treatments of neuroendocrine tumors (NETs) to improve and extend the lives of those living with NETs.
Blog
Grant Funding Announced for NET Cancer Research
Request for Applications Issued The Neuroendocrine Tumor Research Foundation (NETRF) has announced its latest Request for Applications (RFA) and invites innovative research applications in neuroendocrine
May 16, 2018
No Comments
Blog
International Gathering Gives Hope
by Laran Hyder, NETRF Associate Director of Development and Outreach As a NET patient or caregiver, living with neuroendocrine cancer can be an isolating experience.
April 4, 2018
No Comments
Blog
Unraveling the Causes of Small Intestinal NETs
The first step in curing a disease is understanding it. Unfortunately, there is a lot we still don’t know about small-intestinal NETs (SI-NETs). That’s why
March 27, 2018
8 Comments
Blog
Research Today is the Treatment of Tomorrow
by Ronny Allan, NET Patient Activist Doctors and scientists are always looking for better ways to care for patients with cancer; they are looking for
March 26, 2018
2 Comments
Blog
NETRF Awards Six Grants
NETRF awarded six new research grants totaling $1.85 million to leading academic institutions around the world. The goal of the funding is to improve current treatments for neuroendocrine tumors (NETs), an uncommon and poorly understood cancer, which occurs in the body’s hormone-producing cells.
March 5, 2018
3 Comments
Blog
New Hope for Understanding and Treating NETs
World renown laboratory in the Netherlands to grown min-organs in Petri dishes to speed up NET drug testing.
December 14, 2017
No Comments
Blog
Exploring the birth of a carcinoid cancer cell
Much about a carcinoid cancer cell remains a mystery. For that reason, NETRF funds research to understand how and why a neuroendocrine cancer cell comes
November 15, 2017
5 Comments
Blog
PRRT for Pancreatic NETs
NETRF in collaboration with NANETS awarded the 2017 Basic Translational Science Investigator grant to Brian R. Untch, M.D., at Memorial Sloan Kettering Cancer Center for his proposal, “Enhancing Peptide Receptor Radionuclide Therapy in Well-Differentiated Pancreatic Neuroendocrine Tumors.”
November 15, 2017
1 Comment
Blog
A novel agent for imaging NETs
There is a critical need to develop improved diagnostic tools for non-invasive, early detection of NETs in a broader range of patients. New grant-funded research will work towards this goal.
November 15, 2017
10 Comments